WHO ICTRP trial
Renal effects of Saxagliptin and Linagliptin in diabetic nephropathy: A…
ChiCTR-IPR-15006340 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-IPR-15006340 |
|---|---|
| Public title | Renal effects of Saxagliptin and Linagliptin in diabetic nephropathy: A randomized, double-blind, head to head study. |
| Scientific title | Renal effects of Saxagliptin and Linagliptin in diabetic nephropathy: A randomized, double-blind, head to head study. |
| Primary sponsor | Tianjin Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | Diabetic Nephropathy |
| Interventions | Saxagliptin group:with Saxagliptin treatment;Linagliptin group:with Linagliptin treatment |
| Registration date | Apr 28, 2015 |
| Target size | Saxagliptin group:37;Linagliptin group:37 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: